Apixaban for the treatment of cancer-associated venous thromboembolism and left atrial appendage thrombus refractory to optimal anticoagulation with warfarin: a case report.

Koga, Masashi; Sugimoto, Atsuhiko; Furo, Masaki; Iseki, Harukazu

Koga, Masashi; Sugimoto, Atsuhiko; Furo, Masaki; Iseki, Harukazu.

Afiliación

Koga M; Department of Cardiovascular Medicine, Sagamihara Kyodo Hospital, Midori-Ku, Hashimoto, Sagamihara, Kanagawa, Japan.
Sugimoto A; Department of Cardiovascular Medicine, Sagamihara Kyodo Hospital, Midori-Ku, Hashimoto, Sagamihara, Kanagawa, Japan.
Furo M; Department of Cardiovascular Medicine, Sagamihara Kyodo Hospital, Midori-Ku, Hashimoto, Sagamihara, Kanagawa, Japan.
Iseki H; Department of Cardiovascular Medicine, Sagamihara Kyodo Hospital, Midori-Ku, Hashimoto, Sagamihara, Kanagawa, Japan.

Eur Heart J Case Rep ; 2(4): yty135, 2018 Dec.

Article en En | MEDLINE | ID: mdl-31020211

Palabras clave

Cancer-associated venous thromboembolism; Case report; Direct oral anticoagulants; Factor Xa inhibitors; Left atrial appendage thrombus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Eur Heart J Case Rep Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google